RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 11742032)

Published in Lab Invest on December 01, 2001

Authors

S Castel1, R Pagan, F Mitjans, J Piulats, S Goodman, A Jonczyk, F Huber, S Vilaró, M Reina

Author Affiliations

1: Departament de Biologia Cellular, Universitat de Barcelona, Barcelona, Spain.

Articles citing this

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). J Nucl Med (2007) 1.46

Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. Mol Pharm (2008) 1.39

Breaking the one antibody-one target axiom. Proc Natl Acad Sci U S A (2006) 1.26

Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide. Mol Ther (2009) 1.09

Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX. J Virol (2004) 1.08

Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice. J Nucl Med (2009) 0.99

In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD. Eur J Nucl Med Mol Imaging (2007) 0.96

Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharm (2011) 0.94

Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain. Biomaterials (2010) 0.91

Guiding plant virus particles to integrin-displaying cells. Nanoscale (2012) 0.90

Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages. Bioconjug Chem (2013) 0.89

Immobilization of RGD peptide on HA coating through a chemical bonding approach. J Mater Sci Mater Med (2009) 0.86

Intracellular targets of RGDS peptide in melanoma cells. Mol Cancer (2010) 0.85

Atomic basis for the species-specific inhibition of αV integrins by monoclonal antibody 17E6 is revealed by the crystal structure of αVβ3 ectodomain-17E6 Fab complex. J Biol Chem (2014) 0.84

Biological Targeting of Plasmonic Nanoparticles Improves Cellular Imaging via the Enhanced Scattering in the Aggregates Formed. J Phys Chem Lett (2014) 0.84

MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides. J Appl Polym Sci Symp (2014) 0.82

Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery. Mol Pharm (2010) 0.81

Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. Eur J Immunol (2014) 0.78

Ultrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner. Small (2014) 0.77

RGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cells. PLoS One (2014) 0.75

Rosette nanotubes inhibit bovine neutrophil chemotaxis. Vet Res (2010) 0.75

Determining Drug Efficacy Using Plasmonically Enhanced Imaging of the Morphological Changes of Cells upon Death. J Phys Chem Lett (2014) 0.75

Articles by these authors

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem (1999) 2.76

Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med (1985) 2.76

Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nat Nanotechnol (2006) 2.53

Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry (1998) 2.46

Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature (1994) 2.41

Young, gifted.and spurned. Nature (2001) 2.13

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12

New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ (2001) 2.12

Test-retest reliability of the Diagnostic Interview Schedule for Children (DISC 2.1). Parent, child, and combined algorithms. Arch Gen Psychiatry (1995) 2.05

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest (1999) 2.03

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med (1996) 1.99

Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology (1993) 1.79

Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol (1995) 1.71

Inter-regional differences and outcome in unstable angina; analysis of the international ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events. Eur Heart J (2000) 1.71

Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res (1999) 1.66

Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study. Eur Heart J (2002) 1.65

The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell. FEBS Lett (1999) 1.58

Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation (2001) 1.56

Use of synthetic oligoribonucleotides to probe RNA-protein interactions in the MS2 translational operator complex. Nucleic Acids Res (1990) 1.54

Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci (1999) 1.54

p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. EMBO J (1996) 1.52

Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg Am (2000) 1.51

Force required to break alpha5beta1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol Chem (1998) 1.46

Primary breast lymphoma with skin involvement arising in lymphocytic lobulitis. Histopathology (1994) 1.45

Expression of the cystic fibrosis gene in human development. Development (1991) 1.45

Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42

Anaesthesia for carotid endarterectomy: comparison of hypnotic- and opioid-based techniques. Br J Anaesth (2004) 1.41

Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41

Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease. Eye (Lond) (1997) 1.41

Evaluation of an instrumented walkway for measurement of the kinematic parameters of gait. Gait Posture (2000) 1.40

Comparison of the new acceleration spectrum analysis with other time- and frequency-domain analyses of the signal-averaged electrocardiogram. Eur Heart J (1998) 1.39

Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem (1999) 1.38

Europe's Mars mission to pay out for Beagle lander. Nature (2001) 1.38

PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36

Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1999) 1.28

Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology (2004) 1.28

Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem J (1998) 1.27

Oxford meniscal bearing knee versus the Marmor knee in unicompartmental arthroplasty for arthrosis. A Swedish multicenter survival study. J Arthroplasty (1995) 1.22

Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem (2000) 1.22

An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci (1995) 1.21

Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides. Eur J Biochem (1998) 1.20

Adverse life events and resilience. J Am Acad Child Adolesc Psychiatry (1998) 1.20

Sexual conflict in Sepsis cynipsea: female reluctance, fertility and mate choice. J Evol Biol (2003) 1.20

Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol (1990) 1.19

Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med (2001) 1.17

Relationship between specific adverse life events and psychiatric disorders. J Abnorm Child Psychol (2001) 1.15

[A new semisynthesis of human insulin. Tryptic transpeptidation of porcine insulin with L-threonine tert-butyl ester (author's transl)]. Hoppe Seylers Z Physiol Chem (1981) 1.15

Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci (1995) 1.13

Localization of beta 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin. Exp Cell Res (1993) 1.13

rBAT, related to L-cysteine transport, is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development. J Biol Chem (1993) 1.13

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer (2000) 1.11

Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci (2000) 1.10

Worldwide patterns of mitochondrial DNA differentiation in the harbor seal (Phoca vitulina). Mol Biol Evol (1996) 1.09

Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant (2009) 1.08

Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3. Mol Biol Cell (2001) 1.08

Proton transport through a peptide-tethered bilayer lipid membrane by the H(+)-ATP synthase from chloroplasts measured by impedance spectroscopy. Biosens Bioelectron (2002) 1.07

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proc Natl Acad Sci U S A (1999) 1.05

Pulse oximetry is a poor predictor of hypoxemia in stable children with sickle cell disease. Arch Pediatr Adolesc Med (2000) 1.05

Prevention of external ventricular drain--related ventriculitis. Acta Neurochir (Wien) (2005) 1.04

Intrauterine diagnosis: potential complications. Am J Obstet Gynecol (1973) 1.04

Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Cancer Res (1996) 1.03

Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br J Cancer (2002) 1.03

A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med (1994) 1.02

The effect of a perioperative clinical pathway for knee replacement surgery on hospital costs. Anesth Analg (1998) 1.02

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant (2012) 1.00

The influence of ageing and exercise on tendon growth and degeneration--hypotheses for the initiation and prevention of strain-induced tendinopathies. Comp Biochem Physiol A Mol Integr Physiol (2002) 1.00

Lipoprotein lipase in lungs, spleen, and liver: synthesis and distribution. J Lipid Res (1991) 1.00

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation. Bone Marrow Transplant (1997) 1.00

Registered nurses' experiences with an evidence-based home care pathway for myocardial infarction clients. Can J Cardiovasc Nurs (2004) 0.99

Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials (2002) 0.99

Epithelial-mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide. Hepatology (1997) 0.98

Vimentin filaments follow the preexisting cytokeratin network during epithelial-mesenchymal transition of cultured neonatal rat hepatocytes. Exp Cell Res (1996) 0.98

Glucose induces the translocation of glycogen synthase to the cell cortex in rat hepatocytes. Biochem J (1997) 0.98

Ligand binding to heparan sulfate proteoglycans induces their aggregation and distribution along actin cytoskeleton. Mol Biol Cell (1996) 0.97

Intermittent micromotion inhibits bone ingrowth. Titanium implants in rabbits. Acta Orthop Scand (1992) 0.96

The expression of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme-A synthase in neonatal rat intestine and liver is under transcriptional control. Eur J Biochem (1996) 0.96

Glucose induces the translocation and the aggregation of glycogen synthase in rat hepatocytes. Biochem J (1992) 0.96

Synaptic connectivity between cricket auditory interneurons as studied by selective photoinactivation. J Neurosci (1985) 0.95

Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Am J Cardiol (1998) 0.95

Role of glucose 6-phosphate in the translocation of glycogen synthase in rat hepatocytes. Biochem J (1992) 0.95

Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens (2007) 0.95

Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood. Proc Natl Acad Sci U S A (1985) 0.94

Distinct ligand-binding modes for integrin alpha(v)beta(3)-mediated adhesion to fibronectin versus vitronectin. J Biol Chem (2001) 0.94

Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res (1995) 0.93

Purtscher's-like retinopathy in chronic renal failure. Ophthalmology (1992) 0.93

The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1994) 0.93

Effect of sodium chloride concentration on the heat resistance and recovery of Salmonella typhimurium. Int J Food Microbiol (2001) 0.93

Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res (1993) 0.93

Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption. Gastrointest Endosc (1997) 0.92